Inaktiver Wert

Andere Sprachen Medipharm Labs Corp Toronto S.E.

Aktien

CA58504D1006

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5%	27.03.
MediPharm Labs Provides Conference Call Recording Details	27.03.
MediPharm Labs Narrows Q4 Loss, Revenue Grows	27.03.
MediPharm Labs Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	27.03.
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%	27.03.
MediPharm Labs Reports Fourth Quarter and Full Year Results	27.03.
MediPharm Labs Offers Update on German Cannabis Legalization; Up Nearly 6%	25.03.
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	25.03.
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	25.03.
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	25.03.
MediPharm Labs Offers Update on German Cannabis Legalization	25.03.
MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis"	25.03.
MediPharm Labs Corp. Brief: Providing Update on German Cannabis Legalization	25.03.
MediPharm Labs Provides Update on German Cannabis Legalization	25.03.
MediPharm Labs Provides Update on German Cannabis Legalization	25.03.
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results	22.03.
MediPharm Labs Corp. Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	07.02.
MediPharm Labs Corp. Brief: Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	07.02.
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority	07.02.
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program	22.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Medipharm Labs Corp Toronto S.E.

Aktien

CA58504D1006

Andere Sprachen

Filter